
Understanding, Diagnosing, and Using Genetic Testing for Central Core Myopathy
Diagnose Central Core Myopathy with genetic testing. Understand symptoms, clinical evaluation, muscle biopsy, and RYR1 gene mutations for effective management.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Diagnose Central Core Myopathy with genetic testing. Understand symptoms, clinical evaluation, muscle biopsy, and RYR1 gene mutations for effective management.

Genetic testing aids in CADASIL diagnosis by confirming the NOTCH3 mutation, guiding family planning, and informing personalized treatments for better management and outcomes.

Explore Cerebro-Costo-Mandibular Syndrome: symptoms, diagnosis, and the vital role of genetic testing. Learn how genetic insights can guide personalized care plans.

Charcot-Marie-Tooth disease type 1B (CMT1B) is a hereditary neurological disorder that affects the peripheral nerves.

Charcot-Marie-Tooth Disease Type 1E: Learn how genetic testing helps diagnose CMT1E, confirms PMP22 gene mutations, aids family planning, and tailors personalized treatments.

Charcot-Marie-Tooth disease type 2A1 affects peripheral nerves, causing muscle weakness. Genetic testing confirms diagnosis, helps with early intervention, and guides research.

Charcot-Marie-Tooth Disease, Type IA (CMT1A) is a genetic disorder that affects the peripheral nerves, leading to muscle weakness and atrophy, primarily in the legs and feet.

Explore childhood epilepsy with centrotemporal spikes (CECTS), its diagnosis, and the role of genetic testing in identifying mutations, personalizing treatment plans, and…